![Kinichiro Kominami](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kinichiro Kominami
Director/Board Member at
DELTA-FLY PHARMA, INC.
Net worth: 63 767 $ as of 2026-09-29
Profile
Kinichiro Kominami currently works at Perseus Proteomics, Inc., as Independent Non-Executive Outside Director from 2018, Delta-Fly Pharma, Inc., as Independent Outside Director from 2018, Veritas In Silico Inc., as Independent Outside Director from 2019, and Tech & FinStrategy, Inc., as President & Representative Director from 2017.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-21 | 60,000 ( 0.33% ) | 63 767 $ | 2026-09-29 |
Kinichiro Kominami active positions
| Companies | Position | Start |
|---|---|---|
| DELTA-FLY PHARMA, INC. | Director/Board Member | 2018-05-31 |
| PERSEUS PROTEOMICS INC. | Director/Board Member | 2018-05-31 |
| VERITAS IN SILICO INC. | Director/Board Member | 2019-07-31 |
Tech & FinStrategy, Inc.
 Tech & FinStrategy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting and plans preparation support services | President | 2017-08-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Perseus Proteomics, Inc.
 Perseus Proteomics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets antibody-based therapeutics and diagnostics | Health Technology |
Delta-Fly Pharma, Inc.
 Delta-Fly Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the bio-pharmaceutical development business | Health Technology |
Veritas In Silico Inc.
 Veritas In Silico Inc. BiotechnologyHealth Technology Develops drugs against structural motifs on mRNA | Health Technology |
Tech & FinStrategy, Inc.
Tech & FinStrategy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting and plans preparation support services | Commercial Services |
- Stock Market
- Insiders
- Kinichiro Kominami
